Evidence map›Paper›PMID 41316391›Full record

ArticleJournal of health, population, and nutrition2025

Participatory implementation science to enhance knowledge and build the capacity to increase the uptake and sustainability of HPV vaccination among girls in Nigeria.

Peter Kalulu, Olufunto A Olusanya, Abideen Salako, Nkiruka Obodoechina, Maria A Afadapa, Temitope Ojo, Folahanmi T Akinsolu, Joseph Ogbeh, Ucheoma Nwaozuru, Hong Xian and 17 more

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Peter KaluluDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA. kalulu@wustl.edu.
Olufunto A OlusanyaDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.
Abideen SalakoNigerian Institute of Medical Research, Lagos, Nigeria.
Nkiruka ObodoechinaDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.
Maria A AfadapaDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.
Temitope OjoDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.
Folahanmi T AkinsoluNigerian Institute of Medical Research, Lagos, Nigeria.
Joseph OgbehNigerian Institute of Medical Research, Lagos, Nigeria.
Ucheoma NwaozuruDepartment of Implementation Science, School of Medicine, Wake Forest University, Winston-Salem, USA.
Hong XianCollege for Public Health and Social Justice, Saint Louis University, St. Louis, USA.
Adesola Z MusaNigerian Institute of Medical Research, Lagos, Nigeria.
Titilola Gbaja-BiamilaNigerian Institute of Medical Research, Lagos, Nigeria.
Jason J OngMelbourne Sexual Health Center, Alfred Health, Melbourne, Australia.
Priscilla A KabuteySchool of Public Health, Washington University in St. Louis, St Louis, MO, USA.
Caven N NgoeSchool of Public Health, Washington University in St. Louis, St Louis, MO, USA.
Suleiman YusufSchool of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Olayiwola OlaitanCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Idris A OladosuCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Jennifer S SmithDepartment of Epidemiology, University of North Carolina, Chapel Hill, USA.
Kayode O AjenifujaDepartment of Obstetrics and Gynaecology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Ricardo J WrayCollege for Public Health and Social Justice, Saint Louis University, St. Louis, USA.
Benedict N AzuoguDepartment of Community Health, Ebonyi State University, Abakaliki, Nigeria.
Collins O AirhihenbuwaSchool of Public Health, Georgia State University, Atlanta, USA.
Ashley BardonDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.
Joseph D TuckerDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Oliver C EzechiNigerian Institute of Medical Research, Lagos, Nigeria.
Juliet IwelunmorDivision of Infectious Diseases, John T. Milliken Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, USA.

Funding

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)U54CA284110 · NCI · WASHINGTON UNIVERSITY · PI Juliet Iwelunmor · 2023 to 2026
$5.0M
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)R01CA271033 · NCI · WASHINGTON UNIVERSITY · PI OLIVER CHUKWUJEKWU EZECHI, Juliet Iwelunmor · 2022 to 2026
$2.5M
NCI NIH HHS R01 CA271033NCI NIH HHS U54 CA284110NCI NIH HHS U54CA284110
6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) vaccination can prevent cancer in low- and middle-income countries (LMICs), but its uptake remains low, especially in Nigeria. Understanding participatory approaches can help identify local strategies to increase, build capacity for, and sustain vaccine uptake. This study evaluated the effectiveness of an innovation bootcamp in enhancing the knowledge and skills of youth implementers about HPV and cervical cancer as a strategy to increase vaccine uptake among Nigerian girls aged 9-14 years. An innovation bootcamp is an intensive training program that engages end users to build capacity and skills.

methodsThis was a five-week hybrid bootcamp guided by Youth Participatory Action Research (YPAR) and the PEN-3 cultural model at the Nigerian Institute of Medical Research in Lagos, Nigeria. Data were collected using pre- and post-training surveys to assess sociodemographic characteristics, participant preparation, motivations, support needs, baseline learning barriers, the bootcamp process, and knowledge and implementation science research skills (using 9-item and 22-item self-reported scales, respectively). We conducted descriptive analyses of quantitative data and thematic analysis for qualitative, open-ended responses, and we estimated changes in knowledge and skills using the Wilcoxon Signed-Rank test.

resultsFive teams comprised of 16 participants attended the bootcamp, and 13 completed the post-survey. Of the 16 participants, most were female (81%) with an average age of 22 years and resided in the following states: Osun (n = 5), Abuja (n = 4), Lagos (n = 2), Kwara (n = 2), Oyo (n = 2), and Plateau (n = 1). The PEN-3 cultural model highlighted the importance of training and enabling resources. Following the bootcamp, the median knowledge score increased from 34 (IQR 31.0-35.0) to 37 (IQR 35.0-40.0), but this change was not statistically significant (p = 0.086). In contrast, there was a significant increase in research skills score from 54 (IQR 43.0-61.0) to 82 (IQR 73.0-96.0) (p = 0.011).

conclusionsThe bootcamp demonstrated that culturally structured participatory approaches can enhance engagement, knowledge, and skills while cultivating participatory learning communities. Empowering young people with appropriate resources and mentorship can propel sustainable HPV vaccination in Nigeria.

Indexed as

Health Knowledge, Attitudes, PracticeImplementation SciencePapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareUterine Cervical NeoplasmsVaccinationAdolescentCapacity BuildingChildCommunity-Based Participatory ResearchFemaleHumansNigeriaPapillomavirus VaccinesCapacity buildingCervical cancer preventionHPV vaccinationParticipatory implementation scienceYouth engagement

Identifiers

PMID41316391
PMCPMC12664181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.